Toggle navigation
Home
Search
Services
Blog
Contact
About
Targeting the IL-2 Receptor in Diabetes
Brennan, Daniel C.
Brigham and Women's Hospital, Boston, MA, United States
Search 22 grants from Daniel Brennan
Search grants from Brigham and Women's Hospital
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Publications
Comments
Recent in Grantomics:
Your institution
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Residency Training in Gim and/OR Gp
Financial Assistance to Disadvantaged H.P. Students
Health Careers Opportunity Program
An Investigation of the Antilipolytic Effect of Insulin
Environmental Estrogens in Isolated Liver Cell Actions
Recently added grants:
Technology Training and Dissemination
Cancer Center Support Grant
Admin-Core
Cancer Research Career Enhancement and Related Activities
Cancer Cell Biology Research Program
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Postdoctoral Individual National Research Service Award (F32)
Project #
1F32AI007918-01
Application #
3029915
Study Section
Clinical Sciences Subcommittee 1 (CLN)
Project Start
1988-12-31
Project End
Budget Start
1988-07-01
Budget End
1989-06-30
Support Year
1
Fiscal Year
1988
Total Cost
Indirect Cost
Institution
Name
Brigham and Women's Hospital
Department
Type
DUNS #
071723621
City
Boston
State
MA
Country
United States
Zip Code
02115
Related projects
NIH 1990
F32 AI
Targeting the IL-2 Receptor in Diabetes
Brennan, Daniel C. / Brigham and Women's Hospital
NIH 1989
F32 AI
Targeting the IL-2 Receptor in Diabetes
Brennan, Daniel C. / Brigham and Women's Hospital
NIH 1988
F32 AI
Targeting the IL-2 Receptor in Diabetes
Brennan, Daniel C. / Brigham and Women's Hospital
Publications
Brennan, D C; Jevnikar, A M; Takei, F et al.
(1990)
Mesangial cell accessory functions: mediation by intercellular adhesion molecule-1.
Kidney Int 38:1039-46
Comments
Be the first to comment on Daniel Brennan's grant